L’hôpital Larrey est un établissement public de santé situé en France à Toulouse Haute-Garonne. Il fait partie du centre hospitalier universitaire de Toulouse.

During the past decade, Hôpital Larrey conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 29 clinical trials were completed, i.e. on average, 26.6% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 19 clinical trials were completed. i.e. 33.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Larrey" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 13 trials, followed by "University Hospital, Toulouse" with 13 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored and "Actelion" with 8 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Larrey" #1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "Incyte Corporation" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials as a collaborator and "Ministry of Health, France" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Larrey" are "Pulmonary Arterial Hypertension" (9 trials), "Atopic Dermatitis" (8 trials), "Psoriasis" (8 trials), "Non-Small Cell Lung Cancer" (7 trials) and "Carcinoma, Non-Small-Cell Lung" (6 trials). Many other conditions were trialed in "Hôpital Larrey" in a lesser frequency.

Most popular intervention types in "Hôpital Larrey" are "Drug" (94 trials), "Other" (19 trials), "Device" (11 trials), "Biological" (9 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Pemetrexed" (11 trials), "Cisplatin" (8 trials), "Docetaxel" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Larrey" are 138 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 68 active trials in "Hôpital Larrey". 1 are not yet recruiting, 43 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Hôpital Larrey, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Larrey, 6 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 21 trials that are defined as “Not Applicable".